我要投票 护佑在医疗用品行业中的票数:499
· 外 推 电 报 ·
2025-11-22 17:02:22 星期六

【护佑是哪个国家的品牌?】

护佑是什么牌子?「护佑」是 扬子江药业集团有限公司 旗下著名品牌。该品牌发源于江苏省泰州市,由创始人徐镜人在2001-03-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力护佑品牌出海!将品牌入驻外推网,定制护佑品牌推广信息,可以显著提高护佑产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

创建于1971年,拥有中西药并举,处方药与非处方药并重的产品体系,产学研/科工贸一体化的创新型医药企业集团


扬子江药业集团创建于1971年,是一家跨地区、产学研相结合、科工贸一体化的国家大型医药企业集团。集团总部位于江苏省泰州市,现有员工15000人,总占地面积300多万平方米。旗下15家成员公司分布泰州、北京、上海、南京、广州、成都、苏州、常州等地;营销网络覆盖除台湾以外的全国各省、市、自治区。

扬子江药业集团把研发创新作为企业发展战略基点,致力于国家一类新药和创新药物的研发。集团坚持不懈走创新之路,在新药研发上,全面推进“三药并举”战略,以每年按销售额3~4%比例投入新药研发,抢占科技制高点,引进具有国际视野的高端研发创新人才,建立国际化研发体系。目前在研的化学创新药、仿制药、中药和生物药达100多个,确保了短期、中期和长期产品研发有序进行。经过多年的积累和创新,产品体系覆盖10多个领域、10多种剂型、200多个品规。集团一直以市场为导向,研发产品以抗感染、心脑血管、消化系统为主,并积极开拓其它具有增长潜力的用药市场,形成“研发一批、生产一批、储备一批”的产品梯队,有力保证了企业的持续健康发展。

集团根据中医泰斗董建华院士等名老中医的验方,相继成功研发并上市胃苏颗粒、荜铃胃痛颗粒、蓝芩口服液、双花百合片、香芍颗粒、百乐眠胶囊、黄芪精口服液、柴芩清宁胶囊、青乳消颗粒、补肾润肺口服液、神曲消食口服液等一大批疗效独特的中药精品,为无数患者送去健康福音。正在建设的龙凤堂中药项目,将致力于药材自动化前处理——智能投料——原辅料、成品无人输送——机器人码垛——自动控温立体高架库储存等技术攻尖,全力打造现代化中药智能工厂。

集团发展不忘回报社会,多年来在赈灾、扶贫、拥军、助学以及各种人道主义救助活动中始终走在全社会的前列。集团至今连续16多年资助“中华医学科技奖”评选,鼎力支持祖国医学科技进步。汶川大地震发、天津港爆炸、盐城龙卷风灾害发生后,扬子江在第一时间捐赠款物,奉献爱心。

面向未来,奋进中的扬子江药业集团以振兴民族医药为己任,怀着科学、严谨、负责的态度,竭诚为全人类的健康服务。


英文翻译:Founded in 1971, Yangzijiang Pharmaceutical Group, an innovative pharmaceutical enterprise group with the integration of production, research, science, industry and trade, is a large-scale national pharmaceutical enterprise group with the integration of science, industry and trade and the combination of production, research and research. Headquartered in Taizhou City, Jiangsu Province, the group has 15000 employees and covers an area of more than 3 million square meters. Its 15 member companies are distributed in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Suzhou, Changzhou and other places; the marketing network covers all provinces, cities and autonomous regions except Taiwan. Yangzijiang Pharmaceutical Group takes R & D and innovation as the strategic basis of enterprise development, and is committed to the R & D of national first-class new drugs and innovative drugs. The Group continues to take the road of innovation. In terms of new drug research and development, the group comprehensively promotes the strategy of "three drugs simultaneously". It invests in new drug research and development at the proportion of 3-4% of sales every year, seizes the commanding point of science and technology, introduces high-end R & D and innovation talents with international vision, and establishes an international R & D system. At present, more than 100 chemical innovative drugs, generic drugs, traditional Chinese medicine and biological drugs are under research, ensuring the orderly development of short-term, medium-term and long-term products. After years of accumulation and innovation, the product system covers more than 10 fields, more than 10 dosage forms and more than 200 product specifications. The group has always been market-oriented. Its R & D products mainly focus on anti infection, cardio cerebrovascular and digestive system, and actively explore other drug markets with growth potential, forming a product echelon of "R & D, production and storage", which effectively ensures the sustainable and healthy development of the enterprise. The group has successfully developed and listed a large number of excellent TCM products with unique curative effects, such as Weisu granule, bieling Weitong granule, Lanqin oral liquid, Shuanghua Lily tablet, Xiangshao granule, bailemining capsule, Huangqi essence oral liquid, chaiqinqingning capsule, qingruxiao granule, Bushen Runfei oral liquid, Shenqu Xiaoshi oral liquid, according to the prescription of famous old TCM, such as academician Dong Jianhua, the leader of traditional Chinese medicine Countless patients sent health gospel. The longfengtang traditional Chinese medicine project under construction will focus on the technology of automatic pre-processing of traditional Chinese Medicine - Intelligent feeding - raw and auxiliary materials, unmanned transportation of finished products - robot stacking - automatic temperature control three-dimensional elevated warehouse storage, and strive to build a modern intelligent factory of traditional Chinese medicine. The development of the group does not forget to repay the society, and it has always been in the forefront of the whole society in disaster relief, poverty alleviation, supporting the army, education and various humanitarian relief activities for many years. The group has supported the selection of "Chinese medical science and Technology Award" for more than 16 years in a row, making great efforts to support the progress of medical science and technology in China. After the Wenchuan earthquake, Tianjin Port explosion and Yancheng tornado disaster, the Yangtze River donated money and goods for the first time. Facing the future, the striving Yangtze River Pharmaceutical Group takes the rejuvenation of national medicine as its own duty, with a scientific, rigorous and responsible attitude, and wholeheartedly serves the health of all mankind.

本文链接: https://www.waitui.com/brand/4682ce224.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

报告:“成分党”成为美妆主流消费群体

毕马威近日发布的《"颜"值经济新篇章:2025年中国美妆市场行业报告》(以下简称《报告》)显示,据调查,58.8%的消费者将产品成分作为购买决策的首要考量因素,“成分党”成为主流消费群体。与此同时,300-500元中端价格带产品市场份额显著提升,而超低价与高端市场则双双承压,反映出消费者在追求"悦己"体验的同时,更加注重产品的实际功效与性价比。(新浪财经)

2小时前

美联储传声筒:鲍威尔不是降息的最大障碍 美联储内部共识机制濒临瓦解

“美联储传声筒”Nick Timiraos撰文称,特朗普本周表示,他预计在明年5月任命新的美联储主席后,利率将大幅下降。然而,美联储内部反对12月降息声浪越来越大,这意味着他的愿望可能难以实现。无论鲍威尔在12月选择按兵不动还是降息,他都面临近八年任期内最严重的内部阻力。这种分歧可能延续至明年,这意味着,即便更换主席,也并不等于就能确保会有更多降息。一些人担忧,若特朗普无法如愿以偿,可能会采取更激进手段削弱央行独立性,以换取降息。(金十数据APP)

2小时前

第八届进博会,上海合作交流采购团达成意向采购额7.12亿元

11月21日下午,第八届中国国际进口博览会上海市合作交流采购团总结展示交流活动在闵行区虹桥品汇成功举办。据介绍,本届进博会上海市合作交流采购团采购成交再创新高,共达成意向采购额7.12亿元人民币,比上届提升4.71%,累计意向采购额突破30亿元。采购团规模也进一步扩大,分团总数增至33家,共组织30批次、近760人次走进进博会参观交流,参与企业数量创历年新高。(界面新闻)

2小时前

《哪吒2》不参加奥斯卡竞逐

当地时间11月21日,奥斯卡奖的主办方美国电影艺术与科学学院公布了符合资格参与最佳纪录长片、最佳国际影片以及最佳动画长片三个奖项竞逐的影片大名单。在最佳动画长片领域,今年有35部影片有资格“冲奥”,意外的是,《哪吒之魔童闹海》并不在其中。另一方面,《罗小黑战记2》榜上有名。(澎湃新闻)

2小时前

IDEA研究院孵化企业视启未来获近亿元融资

36氪获悉,孵化自IDEA研究院的视觉大模型企业,视启未来(深圳)科技有限公司宣布完成近亿元天使轮融资。本轮由A股上市公司安凯微领投,昊辰资本、德虎资本、元禾璞华、银杏谷资本、力合中科、数字未来、九安智能等机构跟投。

2小时前

本页详细列出关于护佑的品牌信息,含品牌所属公司介绍,护佑所处行业的品牌地位及优势。
咨询